NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Cracker Barrel Posts Loss Amid Logo Backlash and Sales Decline

Cracker Barrel (CBRL) reports $24.6M Q1 loss with revenue down 5.7% as the chain struggles with fallout from controversial logo change and cuts annual guidance.

Cracker Barrel Posts Loss Amid Logo Backlash and Sales Decline
Credit: Joe Raedle/Getty Images North America
Already have an account? Sign in.
12/09/2025 · 5:43 PM
CBRL
/ Don’t stop at just one post.

Related↓

CRACKER BARREL
09/18/2025 · 6:22 AM

Cracker Barrel Faces Tough Times After Rebranding Backlash

Cracker Barrel's stock slumped & traffic fell after rebranding backlash (new logo, modern stores). They reversed plans due to customer outcry. Now focusing on experience, but expect lower revenue & traffic. Prices rising.

/ Subscriber only
/ Read more

Feed↓

GameStop Prepares Bold Bid to Buy eBay
Featured/ 05/01/2026 · 5:42 PM

GameStop Prepares Bold Bid to Buy eBay

GameStop plans to buy eBay to grow big. CEO Ryan Cohen wants to turn it into a $100B company using its strong cash position.

/ Subscriber only
Chinese EV Stocks Slide After Weak April Deliveries – NIO Drops 7.5%
05/01/2026 · 4:37 PM

Chinese EV Stocks Slide After Weak April Deliveries – NIO Drops 7.5%

Nio, XPeng, and Li Auto saw April sales drop from March, but new SUVs and tech could help them recover in the coming months.

/ Subscriber only
FDA Approves First-Ever PROTAC Drug Veppanu for Advanced Breast Cancer with ESR1 Mutation
05/01/2026 · 12:56 PM

FDA Approves First-Ever PROTAC Drug Veppanu for Advanced Breast Cancer with ESR1 Mutation

FDA approved Pfizer/Arvinas Veppanu pill for advanced breast cancer with ESR1 mutation, helping hormone-resistant cases.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe